HCV Treatment Interruptions: Stop Treatment or Keep Going?

South Central AETC Local Partner

Training slides learning objective include:

  • Applying the guidance provided by the AASLD/IDSA on hepatitis C virus (HCV) direct-acting antiviral (DAA) treatment interruptions
  • Identifying when patients should have DAA therapy continued vs. when DAA therapy should be stopped
  • Describing the data in patients with incomplete
Browse more